Custom Search

Ketoconazole News

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo

Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology, announced that it will package its seborrheic dermatitis treatment Xolegel(r) (ketoconazole,...

Johnson & Johnson launches Nizoral 100 ml bottles in India

Janssen-Cilag, a division of Johnson & Johnson Ltd. India, has announced the launch of Nizoral 100ml bottles in the Indian market. Nizoral , a clinically proven dandruff treatment shampoo, is now available to the consumers for...

Anti-fungal agent that curbed cocaine use in rodents has opposite effect in humans

Ketoconazole, an anti-fungal agent that helps curb cocaine use in laboratory rats, stimulates rather than reduces cocaine and heroin use in humans, according to a study by researchers at Yale School of Medicine.

DiObex Takes Novel Cortisol Synthesis Inhibitor Into Phase 2 Clinical Trial

DiObex, Inc., a privately-held pharmaceutical company focused on the development of therapeutics to treat metabolic diseases, today announced that it has begun treating patients with type 2 diabetes in a randomized,...

Barrier Therapeutics Announces FDA Acceptance of Its New Drug Application for Sebazole(TM) Topical Gel

Barrier Therapeutics, Inc. (NasdaqNM:BTRX ), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing...

Displaying results 1 to 5 out of 6



Next >

Use of this site is subject to the following terms of use